EBS
Emergent BioSolutions Inc.
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · US
$6.20
−0.56%0
Insider buys (3m)
1
Insider sells (3m)
-$25.2K
Net value (3m)
-22.7%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 2, 2026 | Williams Paul Anthony · officer: SVP, Products Business | Sale | 3,000 | $8.40 |
| Jun 10, 2026 | Williams Paul Anthony · officer: SVP, Products Business | F-InKind | 694 | $8.00 |
| Jun 10, 2026 | Glessner Coleen · officer: EVP, Quality & Ethics, and CPL | F-InKind | 2,018 | $8.00 |
| Jun 10, 2026 | LINDAHL RICHARD S · officer: EVP, Chief Financial Officer | F-InKind | 3,964 | $8.00 |
| Jun 10, 2026 | Hartzel William · officer: SVP, Bioservices | F-InKind | 1,741 | $8.00 |
| May 4, 2026 | Katkin Keith · director | Sale | 15,481 | $8.28 |
| May 4, 2026 | White Marvin L · director | A-Award | 25,344 | $0.00 |
| May 4, 2026 | Fowler Neal Franklin · director | A-Award | 25,344 | $0.00 |
| May 4, 2026 | Richard Ronald · director | A-Award | 11,296 | $7.99 |
| May 4, 2026 | Katkin Keith · director | A-Award | 25,344 | $0.00 |
| May 4, 2026 | Richard Ronald · director | A-Award | 25,344 | $0.00 |
| May 4, 2026 | Dayal Sujata Tyagi · director | A-Award | 25,344 | $0.00 |
| May 4, 2026 | Zoon Kathryn C · director | A-Award | 25,344 | $0.00 |
| May 4, 2026 | DeGolyer Donald W · director | A-Award | 11,296 | $7.99 |
| May 4, 2026 | DeGolyer Donald W · director | A-Award | 25,344 | $0.00 |
| May 4, 2026 | White Marvin L · director | A-Award | 11,296 | $7.99 |
| May 4, 2026 | Katkin Keith · director | A-Award | 11,296 | $7.99 |
| May 4, 2026 | DeGolyer Donald W · director | Sale | 14,527 | $8.36 |
| May 4, 2026 | Harsanyi Zsolt · director, officer: Chairman | A-Award | 11,296 | $7.99 |
| May 4, 2026 | Dayal Sujata Tyagi · director | Sale | 980 | $8.94 |
| May 4, 2026 | FOWLER JOHN D JR · director | A-Award | 25,344 | $0.00 |
| May 4, 2026 | Zoon Kathryn C · director | Sale | 1,057 | $8.97 |
| May 4, 2026 | DeGolyer Donald W · director | Sale | 954 | $8.96 |
| May 4, 2026 | Zoon Kathryn C · director | A-Award | 11,296 | $7.99 |
| May 4, 2026 | Zoon Kathryn C · director | Sale | 16,145 | $8.36 |
| May 4, 2026 | Dayal Sujata Tyagi · director | A-Award | 11,296 | $7.99 |
| May 4, 2026 | Dayal Sujata Tyagi · director | Sale | 12,781 | $8.36 |
| May 4, 2026 | Fowler Neal Franklin · director | A-Award | 11,296 | $7.99 |
| May 4, 2026 | FOWLER JOHN D JR · director | A-Award | 11,296 | $7.99 |
| May 4, 2026 | Harsanyi Zsolt · director, officer: Chairman | A-Award | 25,344 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 71Increased 139Reduced 119Sold out 25
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 4,716,599 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 4,341,462 | May 13, 2026 |
| DIMENSIONAL FUND ADVISORS LP | Increased | 3,076,646 | Aug 11, 2026 |
| STATE STREET CORP | Increased | 2,929,238 | Aug 7, 2026 |
| STATE STREET CORP | Increased | 2,849,701 | May 15, 2026 |
| AMERICAN CENTURY COMPANIES INC | Increased | 2,770,448 | Aug 12, 2026 |
| DIMENSIONAL FUND ADVISORS LP | Increased | 2,757,158 | May 7, 2026 |
| AMERICAN CENTURY COMPANIES INC | Reduced | 2,425,722 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 2,257,995 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Reduced | 2,198,839 | Aug 13, 2026 |
| LSV ASSET MANAGEMENT | Increased | 1,695,851 | Aug 6, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | Reduced | 1,506,075 | May 15, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | Increased | 1,381,624 | May 13, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | Reduced | 1,344,323 | Aug 13, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 1,337,243 | Aug 12, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 2, 2026